HealthShares European Drugs (HRJ)
-
Quote & Analysis
-
Forum
Loading...
Symbols:
HRJ Forum Topics
Recent HRJ Articles
- Struggling ETFs
- Europe's Plan to Narrow the Pharma Gap
- ETF Fund Revenues: A View from the Bottom
- HealthShares ETFs: Diagnostics Appears a Winner
- ETF Performance Over the Past Week: Four Metrics of Comparison
- Are HealthShares ETFs Too Specialized?
- Healthcare, Pharma and Biotech ETFs
- Two New HealthShares ETFs
- HealthShares ETF Family Expands
- Sixty-Seven ETF Filings For a New Year
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
loading ...
ocks
Struggling ETFs [view article]
I think its unfair to list NETS etfs in this list even though they have very few assets.NETS launched a whole bunch of these country specific etfs like DAX for Germany recently. So it may take some time before they grow. What do other readers think? ReplyStruggling ETFs [view article]
also etns may be easier to create by issuer than etfsif a demand appears
the issue is whether ubs feels it pays to have resources devoted to a 5 mln indexed certificate of deposit (uag)
plus timing, nets may take some time to take off Reply
Struggling ETFs [view article]
in second tableisn't turnover more relevant than volume?
ok brk is rather a mouthfull
but on this scale een seems twice as illiquid as ifeu, although ranked otherwise Reply
Tiedeman
ETF Fund Revenues: A View from the Bottom [view article]
Nice data! Thanks! ReplyEditors
General Discussion on HRJ
Is this a buy or a sell? ReplyHealthcare, Pharma and Biotech ETFs [view article]
The Matt Hougan article on theme ETF expenses is helpful -- thanks for the pointer. He's right -- makes you want to buy the stocks of the ETF firms more than the ETFs themselves. ReplyBrochstein
Are HealthShares ETFs Too Specialized? [view article]
When I first learned of the HealthShares concept, I was rather excited. I had always found that there were very few healthcare funds that invested in smaller companies (the few that do are actively managed). Any sort of passive vehicle was heavily weighted by Big Pharma, as are most of the actively managed ones.Well, these guys have gone WAY too far. This is far too specialized. Any investors in these funds had better be prepared to be long-term holders, as the liquidity will probably never be very good. Perhaps going as a mutual fund might have made more sense. Reply
Jackson
Healthcare, Pharma and Biotech ETFs [view article]
Have we missed out any ETFs here? Or any Seeking Alpha articles that are important to understanding them? If so, please leave a comment and let us know! ReplySixty-Seven ETF Filings For a New Year [view article]
I believe Barclay's launched an ETN, exchange-traded note rather than an ETF. ReplySixty-Seven ETF Filings For a New Year [view article]
Barclays and Powershares were to launch India ETF's on Dec 20th. Nothing has happened. Both will not comment. Anyone know the status ? Reply